[Minimally invasive radical prostatectomy: Contribution of robotic support, functional and oncological outcomes]

Bull Cancer. 2016 May;103(5):461-8. doi: 10.1016/j.bulcan.2016.02.006. Epub 2016 Mar 16.
[Article in French]

Abstract

Objectives: Radical prostatectomy (RP) remains a standard for localized prostate cancer treatment. The objective of this study is to present this operating technique of the robot-assisted radical prostatectomy (PR-RA) and to evaluate oncological and functional results as well as on the surgical safety.

Methods: A first series of 1679 patients consecutively operated in our institution with this technique from 2005 to 2010 and with a 5-year follow-up evaluated in 2014. The oncology monitoring is ensured with a PSA test every six months during the first three years and once a year the years after if the level remains undetectable.

Results: The oncologic outcomes show 17.4% for pT2 stages and 36.9% for pT3 stages positive margins. The level of biological recurrence is 21.27% with an average delay of 88 months as the time needed for the recurrence to occur. At 12 months, urinary continence (0-1pad/day) returned at 94% of all patients and potency with successful penetration for all men is 61.1% and 88.8% for men with sexual activity before surgery.

Conclusions: The technique PRRA seems to be a reliable technique whose functional results studied from meta-analysis seem to be superior in terms of rapidity of recovery of the continence and erection in comparison with classical surgical or laparoscopic approach.

Keywords: Continence; Erection; Oncological outcomes; Prostatectomie radicale robot-assistée; Robot-assisted radical prostatectomy; Résultats oncologiques; Érection.

Publication types

  • Evaluation Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Erectile Dysfunction / etiology
  • Humans
  • Male
  • Margins of Excision
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Penile Erection
  • Postoperative Complications
  • Prostate-Specific Antigen / blood
  • Prostatectomy / adverse effects
  • Prostatectomy / instrumentation
  • Prostatectomy / methods*
  • Prostatic Neoplasms / blood
  • Prostatic Neoplasms / pathology
  • Prostatic Neoplasms / surgery*
  • Robotic Surgical Procedures / adverse effects
  • Robotic Surgical Procedures / instrumentation
  • Robotic Surgical Procedures / methods*
  • Time Factors
  • Treatment Outcome
  • Urinary Incontinence / etiology

Substances

  • Prostate-Specific Antigen